![Yu Biao Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yu Biao Zhao
Directeur/Membre du Conseil chez
CHINA NT PHARMA GROUP COMPANY LIMITED
Profil
Yu Biao Zhao is currently an Independent Director at Huafon Microfibre (Shanghai) Co., Ltd. since 2019 and an Independent Non-Executive Director at China NT Pharma Group Co., Ltd. since 2019.
Former positions include Chairman at Tianzhi Fund Management Co. Ltd. from 2002 to 2017, Chairman & General Director at China Nature Asset Management Co., Ltd., Manager at Jilin Trust Investment Co. from 1990 to 1996, General Manager at Shanghai Jinluda Investment Management Co. Ltd. from 2000 to 2002, and General Manager-Securities Business Department at Jilin Trust Investment Co. from 1996 to 2000.
Education includes a doctorate degree from Jilin University conferred in 2013.
Postes actifs de Yu Biao Zhao
| Sociétés | Poste | Début |
|---|---|---|
| CHINA NT PHARMA GROUP COMPANY LIMITED | Directeur/Membre du Conseil | 31/12/2019 |
Anciens postes connus de Yu Biao Zhao
| Sociétés | Poste | Fin |
|---|---|---|
| HUAFON MICROFIBRE (SHANGHAI) CO., LTD. | Directeur/Membre du Conseil | 13/06/2025 |
Tianzhi Fund Management Co. Ltd.
 Tianzhi Fund Management Co. Ltd. Investment ManagersFinance Operates fund manager | Président | 01/05/2017 |
Shanghai Jinluda Investment Management Co. Ltd. | Corporate Officer/Principal | 01/12/2002 |
Jilin Trust Investment Co. /Hubei/ | Corporate Officer/Principal | 01/12/2000 |
Jilin Trust Investment Co. | Corporate Officer/Principal | 01/04/1996 |
Formation de Yu Biao Zhao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
China Nature Asset Management Co., Ltd.
 China Nature Asset Management Co., Ltd. Investment ManagersFinance CNAM manages portfolios invested primarily in Chinese securities actively. They manage equity, bonds and money-markets through a range of investment vehicles including pure equity funds, a balanced fund and a money-markets fund. The firm uses a core-satellite strategy. They implemented this strategy by actively managing the satellite portion of the fund, with a focus on good growth potential small- and mid-cap companies, while managing the core portion of the fund passively. CNAM’s investment approach is team-based and research-driven. Their investment decisions are based from the in-house fundamental and quantitative research. | Finance |
Jilin University
 Jilin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Huafon Microfibre (Shanghai) Co., Ltd.
 Huafon Microfibre (Shanghai) Co., Ltd. TextilesProcess Industries Manufactures and sells ultra-fiber materials | Process Industries |
China NT Pharma Group Co., Ltd.
 China NT Pharma Group Co., Ltd. BiotechnologyHealth Technology Engages in the research, development, manufacture and sale of drugs and vaccine products | Health Technology |
Tianzhi Fund Management Co. Ltd.
Tianzhi Fund Management Co. Ltd. Investment ManagersFinance Operates fund manager | Finance |
Jilin Trust Investment Co. | |
Shanghai Jinluda Investment Management Co. Ltd. | |
Jilin Trust Investment Co. /Hubei/ |
